The Hydrolysis of the Prostaglandin Analog Prodrug Bimatoprost to 17-Phenyl-trinor PGF 2 α by Human and Rabbit Ocular Tissue
- 1 April 2003
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 19 (2) , 97-103
Abstract
Bimatoprost (Lumigan™), the ethyl amide derivative of the potent prostaglandin FP agonist 17-phenyl-trinor PGF2α, has been reported to be a member of a pharmacologically unique class of ocular hypotensive agents. To confirm that bimatoprost, which is intrinsically active as an FP prostaglandin agonist, is also a prostaglandin analog prodrug, the hydrolysis of bimatoprost by ocular tissues was studied by incubating solutions containing bimatoprost with either human or rabbit ocular tissue. The ethyl amide group of bimatoprost was hydrolyzed by rabbit and human cornea, iris/ciliary body and Thasclera to produce the expected carboxylic acid product, 17-phenyl-trinor PGF2α. The rate of hydrolysis by human and rabbit cornea and iris/ciliary body is similar, whereas the rate of hydrolysis by the sclera is slower in humans than in rabbits. These studies show that human and rabbit ocular tissue (cornea, iris/ciliary body and sclera) can convert bimatoprost to the potent prostaglandin FP agonist 17-phenyl-trinor PGF2α. Separate in vitro studies clearly show that both bimatoprost and 17-phenyl-trinor PGF2α have affinity for and are agonists at the human FP receptor. Taken together, the data strongly suggests that the ocular hypotensive effect of bimatoprost can be attributed to its activity as a prostaglandin receptor agonist either directly or through its role as a prostaglandin agonist prodrug.Keywords
This publication has 5 references indexed in Scilit:
- Identification and Characterization of the Ocular Hypotensive Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist, and AL-6598, a DP Prostaglandin Receptor AgonistSurvey of Ophthalmology, 2002
- 3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agentsBioorganic & Medicinal Chemistry, 2002
- Bimatoprost and its free acid are prostaglandin FP receptor agonistsEuropean Journal of Pharmacology, 2001
- The Pharmacology of Bimatoprost (Lumigan™)Survey of Ophthalmology, 2001
- Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular BarriersInflammation, 2000